Binding and uptake of novel RGD micelles to the α_vβ₃ integrin receptor for targeted drug delivery

References

• Kedar U, Phutane P, Shidhaye S, Kadam V. Advances in polymeric micelles for drug delivery and tumor targeting. Nanomedicine 2010;6:714–29
   PubMed Web of Science ®Google Scholar
• Adiseshaiah PP, Hall JB, Mcneil SE. Nanomaterial standards for efficacy and toxicity assessment. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2010;2:99–112
   PubMed Web of Science ®Google Scholar
• Peer D, Karp JM, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007;2:751–60
   PubMed Web of Science ®Google Scholar
• Wang W, Wu Q, Pasuelo M, et al. Probing for integrin αvβ3 binding of RGD peptides using fluorescence polarization. Bioconjug Chem 2005;16:729–34
   PubMed Web of Science ®Google Scholar
• Singh R, Lillard JW Jr. Nanoparticle-based targeted drug delivery. Exp Mol Pathol 2009;86:215–23
   PubMed Web of Science ®Google Scholar
• Xiong X-B, Mahmud A, Uludag H, Lavasanifar A. Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(E-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells. Biomacromolecules 2007;8:874–84
   PubMed Web of Science ®Google Scholar
• Jones M, Leroux J. Polymeric micelles – a new generation of colloidal drug carriers. Eur J Pharm Biopharm 1999;48:101–11
   PubMed Web of Science ®Google Scholar
• Kabanov AV, Lemieux P, Vinogradov S, Alakhov V. Pluronic block copolymers: novel functional molecules for gene therapy. Adv Drug Deliv Rev 2002;54:223–33
   PubMed Web of Science ®Google Scholar
• Gaucher G, Dufresne MH, Sant VP, et al. Block copolymer micelles: preparation, characterization and application in drug delivery. J Control Release 2005;109:169–88
   PubMed Web of Science ®Google Scholar
• Niece KL, Hartgerink JD, Donners JJ, Stupp SI. Self-assembly combining two bioactive peptide-amphiphile molecules into nanofibers by electrostatic attraction. J Am Chem Soc 2003;125:7146–7
   PubMed Web of Science ®Google Scholar
• Rangel-Yagul CO, Pessoa A Jr, Blankschtein D. Two-phase aqueous micellar systems – an alternative method for protein purification. Braz J Chem Eng 2004;21:531–44
   Web of Science ®Google Scholar
• Shen SI, Kotamraj PR, Bhattacharya S, et al. Synthesis and characterization of RGD-fatty acid amphiphilic micelles as targeted delivery carriers for anticancer agents. J Drug Target 2007;15:51–8
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release 2011;73:137–72
   Google Scholar
• Chen JX, Wang HY, Li C, et al. Construction of surfactant-like tetra-tail amphiphilic peptide with RGD ligand for encapsulation of porphyrin for photodynamic therapy. Biomaterials 2011;32:1678–84
   PubMed Web of Science ®Google Scholar
• Aulisa L, Forraz N, Mcguckin C, Hartgerink JD. Inhibition of cancer cell proliferation by designed peptide amphiphiles. Acta Biomater 2009;5:842–53
   PubMed Web of Science ®Google Scholar
• Javali NM, Raj A, Saraf P, et al. Fatty acid-RGD peptide amphiphile micelles as potential paclitaxel delivery carriers to alpha(v)beta (3)integrin overexpressing tumors. Pharm Res 2012;29:3347–61
   PubMed Web of Science ®Google Scholar
• Wang YG, Wang X, Zhang YF, et al. RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells. J Drug Target 2009;17:459–67
   PubMed Web of Science ®Google Scholar
• Rerat V, Dive G, Cordi AA, et al. αvβ3 Integrin-targeting Arg-Gly-Asp (RGD) peptidomimetics containing oligoethylene glycol (OEG) spacers. J Med Chem 2009;52:7029–43
   PubMed Web of Science ®Google Scholar
• Ratnikov BI, Rozanov DV, Postnova TI, et al. An alternative processing of integrin alpha(v) subunit in tumor cells by membrane type-1 matrix metalloproteinase. J Biol Chem 2002;277:7377–85
   PubMed Web of Science ®Google Scholar
• Liu S. Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging. Mol Pharm 2006;3:472–87
   PubMed Web of Science ®Google Scholar
• Cheng C, Komljenovic D, Pan L, et al. Evaluation of treatment response of cilengitide in an experimental model of breast cancer bone metastasis using dynamic PET with 18F-FDG. Hell J Nucl Med 2011;14:15–20
   PubMed Web of Science ®Google Scholar
• Aznavoorian S, Stracke ML, Parsons J, et al. Integrin alphavbeta3 mediates chemotactic and haptotactic motility in human melanoma cells through different signaling pathways. J Biol Chem 1996;271:3247–54
   PubMed Web of Science ®Google Scholar
• Sturm RA, Satyamoorthy K, Meier F, et al. Osteonectin/SPARC induction by ectopic beta(3) integrin in human radial growth phase primary melanoma cells. Cancer Res 2002;62:226–32
   PubMed Web of Science ®Google Scholar
• Li E, Brown SL, Stupack DG, et al. Integrin alpha(v)beta1 is an adenovirus coreceptor. J Virol 2001;75:5405–9
   PubMed Web of Science ®Google Scholar
• Pfaff A, Schallon A, Ruhland TM, et al. Magnetic and fluorescent glycopolymer hybrid nanoparticles for intranuclear optical imaging. Biomacromolecules 2011;12:3805–11
   PubMed Web of Science ®Google Scholar
• Adams ML, Kwon GS. The effects of acyl chain length on the micelle properties of poly(ethylene oxide)-block-poly(N-hexyl-l-aspartamide)-acyl conjugates. J Biomater Sci Polym Ed 2002;13:991–1006
   PubMed Web of Science ®Google Scholar
• Wiradharma N, Tong YW, Yang YY. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect. Biomaterials 2009;30:3100–9
   PubMed Web of Science ®Google Scholar
• Dong H, Dube N, Shu JY, et al. Long-circulating 15 nm micelles based on amphiphilic 3-helix peptide-PEG conjugates. ACS Nano 2012;6:5320–9
   PubMed Web of Science ®Google Scholar
• Welsh DJ, Smith DK. Comparing dendritic and self-assembly strategies to multivalency–RGD peptide-integrin interactions. Org Biomol Chem 2011;9:4795–801
   PubMed Web of Science ®Google Scholar
• Sahay G, Alakhova DY, Kabanov AV. Endocytosis of nanomedicines. J Control Release 2010;145:182–95
   PubMed Web of Science ®Google Scholar
• Lavasanifar A, Samuel J, Kwon GS. Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery. Adv Drug Deliv Rev 2002;54:169–90
   PubMed Web of Science ®Google Scholar
• Mahmud A, Lavasanifar A. The effect of block copolymer structure on the internalization of polymeric micelles by human breast cancer cells. Colloids Surf B Biointerfaces 2005;45:82–9
   PubMed Web of Science ®Google Scholar
• Garanger E, Boturyn D, Jin Z, et al. New multifunctional molecular conjugate vector for targeting, imaging, and therapy of tumors. Mol Ther 2005;12:1168–75
   PubMed Web of Science ®Google Scholar
• Jin ZH, Furukawa T, Galibert M, et al. Noninvasive visualization and quantification of tumor alphaVbeta3 integrin expression using a novel positron emission tomography probe, 64Cu-cyclam-RAFT-c(-RGDfK-)4. Nucl Med Biol 2011;38:529–40
   PubMed Web of Science ®Google Scholar
• Bodary SC, Mclean JW. The integrin beta 1 subunit associates with the vitronectin receptor alpha v subunit to form a novel vitronectin receptor in a human embryonic kidney cell line. J Biol Chem 1990;265:5938–41
   PubMed Web of Science ®Google Scholar
• Raymond E, Hanauske A, Faivre S, et al. Effects of prolonged versus short-term exposure paclitaxel (Taxol) on human tumor colony-forming units. Anticancer Drugs 1997;8:379–85
   PubMed Web of Science ®Google Scholar
• Cai LL, Liu P, Li X, et al. RGD peptide-mediated chitosan-based polymeric micelles targeting delivery for integrin-overexpressing tumor cells. Int J Nanomed 2011;6:3499–508
   PubMed Web of Science ®Google Scholar
• Danhier F, Lecouturier N, Vroman B, et al. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. J Control Release 2009;133:11–17
   PubMed Web of Science ®Google Scholar
• Wang J, Mongayt D, Torchilin VP. Polymeric micelles for delivery of poorly soluble drugs: preparation and anticancer activity in vitro of paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)-lipid conjugate and positively charged lipids. J Drug Target 2005;13:73–80
   PubMed Web of Science ®Google Scholar